Artificial Ventilation and Anaesthesia Masks Market

Artificial Ventilation and Anaesthesia Masks Outlook (2022 to 2032)

In 2021, the Global Artificial Ventilation and Anaesthesia Masks market were estimated to be worth around USD 2.3 billion. With the increasing expenditure incurred on Artificial Ventilation and Anaesthesia Masks worldwide recently, the market is expected to reach a worth of about USD 3.9 billion by the end of 2032, with a projected CAGR of 5.0% from 2022 to 2032. From 2017 to 2021, the Artificial Ventilation and Anaesthesia Masks Market experienced a growth of 5.7%.

Attributes	Details
Global Artificial Ventilation and Anaesthesia Masks Market Size (2021)	USD 2.3 billion
Global Artificial Ventilation and Anaesthesia Masks Market Size (2022)	USD 2.4 billion
Projected Market Value (2032)	USD 3.9 billion
Global Market Growth Rate (2022 to 2032)	5% CAGR
United States Growth Rate (2022 to 2032)	4.8% CAGR
Key Companies Profiled	CareFusion Corporation; Air Liquide Healthcare; Koninklijke Philips N.V.; Fisher and Paykel Healthcare; ResMed; Ambu A/S; Hamilton Medical; Acutronic Medical Systems; GaleMed; HOFFRICHTER GmbH; Dragerwerk SA

More than 50% of patients admitted to an intensive care unit (ICU) receive a treatment involving Artificial Ventilation and Anaesthesia Masks. The rising geriatric population is one of the key factors boosting the artificial ventilation and anaesthesia masks market. In 2012, the United Nations projected the geriatric population to rise to over 2 billion by 2050. A rise in the geriatric population often increases chronic diseases such as sleep apnea devices, cancer, COPD, kidney failure, and coronary artery diseases. This boosts the demand for surgical procedures, and in turn, increases the artificial ventilation and anaesthesia masks.

The artificial ventilation and anaesthesia mask market is also boosted by the increasing number of COPD patients. The disease is likely to be the third leading cause of death globally as estimated by WHO. Around 12.7 million adults have been reported to have COPD in the USA alone. The growing need for long-term home care and emergency treatment for lung diseases in adults as well as children is expected to boost demand for artificial ventilation and anaesthesia masks in the near future.

The demand for Artificial Ventilators has increased due to the availability of both, invasive and non-invasive ventilators in the market. Similarly, anaesthesia masks are also available for different cases like full face masks, nasal masks, hybrid masks, oral masks, nasal pillows etc. However, the high cost of artificial ventilation in healthcare is expected to slow the growth of the market in certain developing nations.

Artificial Ventilation and Anaesthesia Masks are used most in operation rooms and account for 51.7% of the market share. From 2017 to 2021, the use of Artificial Ventilation and Anaesthesia Masks in operation rooms has increased with a CAGR of 5.5% and is expected to experience a CAGR of 4.8% in the next ten years, from 2022 to 2032. This is largely due to various policies implemented by governments worldwide to make public healthcare accessible to everyone. Every year, more than 340 million operations are performed worldwide, providing huge opportunities for the Artificial Ventilation and Anaesthesia Masks Market.

Recently, the demand for Artificial Ventilation and Anaesthesia Masks are increasing due to their increasing use in-home care. Especially during the pandemic, when most patients wanted to avoid hospitals.

Region-wise Insights

Which region holds the largest market for Artificial Ventilation and Anaesthesia Masks market?

North America holds the largest market for Artificial Ventilation and Anaesthesia Masks. From 2017 to 2021, the North American Artificial Ventilation and Anaesthesia Masks market experienced a CAGR of 5.3% and is projected to see a CAGR of 4.7% in the next ten years.

According to a study an American is expected to get seven operations done on average in his or her entire lifetime and the number of the USA patients who get any kind of complication from surgery is around 1.5 million thus, increasing the demand for Artificial Ventilation and Anaesthesia Masks.

Another key driving factor in the North American Artificial Ventilation and Anaesthesia Masks Market is the increasing rates of chronic diseases and surgeries in Canada. Approximately 31 out of 100,000 Canadians die from chronic respiratory diseases, as per 2020 reports. And around 2 million surgeries are performed in Canada every year. All these factors are driving the Artificial Ventilation and Anaesthesia Masks Market in North America.

Country-wise Insights

The USA Artificial Ventilation and Anaesthesia Masks Market

The United States has the largest market for Artificial Ventilation and Anaesthesia Masks, which is projected to reach a valuation of USD 1.4 billion by 2032. From 2017 to 2021, the market in the United States grew at a CAGR of 4.8%. Between 2022 and 2032, the United States is expected to be a market with a USD 509.3 million absolute dollar opportunity.

In the United States, every year 5 million people are admitted to ICUs. The number of Americans that were affected by chronic sleep disorders as per a report published by the National Sleep Foundation in 2012. This is expected to increase the demand for Ventilation Equipment and Anaesthesia Masks in the next ten years as these patients are more likely to visit the emergency department and intensive care unit.

Another reason which is helping in boosting the United States Artificial Ventilation and Anaesthesia masks Market is the introduction of The Affordable Care Act by The United States as more patients are now encouraged to opt for surgical treatments.

China Artificial Ventilation and Anaesthesia Masks Market

China’s market is still in the budding stage. China’s Market is projected to reach a valuation of USD 280.4 million by 2032. From 2017 to 2021, the market in China grew at a CAGR of 4.3%. Between 2022 and 2032, China is expected to be a market with a USD 96.8 million absolute dollar opportunity. In 2020, critical care artificial ventilators and anaesthesia masks made up more than 70% of the overall artificial ventilators and anaesthesia masks market in China.

A key reason for the growth of the Artificial Ventilation and Anaesthesia Masks Market in China is the growing older population in the country. The older population in China is expected to reach 198 million by the year 2025, as per the United States Census Bureau. This provides ample opportunities for players in the Artificial Ventilation and Anaesthesia Masks Market. China also exported the most number of Artificial Ventilators and Anaesthesia Masks worldwide, during the pandemic. China exported 16,000 artificial ventilators and anaesthesia masks in just one month during the pandemic.

In 2021, the leading players in China’s Artificial Ventilation and Anaesthesia Masks were Getinge AB, Dragerwerk AG & Co KGaA, Nihon Kohden Corp and Hamilton Medical AG.

Japan Artificial Ventilation and Anaesthesia Masks Market

The Market for Artificial Ventilation and Anaesthesia Market in Japan is expected to experience a CAGR of 3.4% in the next ten years with an absolute dollar opportunity of USD 64.8 million. By 2032, the Japanese market for Artificial Ventilation and Anaesthesia Market is expected to be worth USD 226.1 million.

Competitive Landscape

Artificial Ventilation and Anaesthesia Masks market is moderately competitive and has numerous players. Many key companies are now focusing on collaborating on new research and development activities.

The key companies operating in the Artificial Ventilation and Anaesthesia Masks Market are CareFusion Corporation, Air Liquide Healthcare, Koninklijke Philips N.V., Fisher and Paykel Healthcare, ResMed, Ambu A/S, Acutronic Medical Systems, GaleMed, HOFFRICHTER GmbH and Dragerwerk SA.

Some of the recent developments by the key providers of Artificial Ventilation and Anaesthesia Masks are as follows:

• In November 2020, Besmed launched FitMax CPAP Face Mask a new anaesthetic gas mask. According to the manufacturer, this mask is for those people who cannot find adequate comfort with full-face or nasal masks.
• In April 2020, the NKV-550 series ventilator can now be produced and sold in Japan, according to a statement from the Nihon Kohden Group. In 2019, the Nihon Kohden Group introduced the NKV-550 series ventilator, which is sold to hospitals across the world.
• In July 2019, a novel anaesthesia mask dubbed Nuflow single-use cannulas for high-flow oxygen therapy in newborns was introduced, according to Hamilton Medical.
• In March 2019, to combine the MedFusion 4000 wireless syringe infusion pumps, Smiths Medical announced its partnership with HCA Capital Division.

Key Segments Covered in Artificial Ventilation and Anaesthesia Masks Market Survey

Artificial Ventilation and Anaesthesia Masks Market by Application:

• Operation Room
• Intensive Care Unit
• Emergency Room
• Dental
• Home Care

Artificial Ventilation and Anaesthesia Masks Market by Risk of the Procedure:

• High Risk Patients
• Moderate Risk
• Standard Patients

Artificial Ventilation and Anaesthesia Masks Market by Region:

• North America
• Europe
• APAC
• Middle East and Africa (MEA)
• Latin America

Frequently Asked Questions

How much is the global Artificial Ventilation and Anaesthesia Masks Market currently worth?

The global Artificial Ventilation and Anaesthesia Masks Market were valued at USD 2.3 billion in 2021.

What is the Artificial Ventilation and Anaesthesia Masks Market Forecast through 2032?

Over the projected period, the Artificial Ventilation and Anaesthesia Masks Market are expected to increase at a rate of 5%, reaching a value of USD 3.9 billion by 2032.

What is a key trend in the Artificial Ventilation and Anaesthesia Masks Market?

The involvement of technology in Artificial Ventilation and Anaesthesia Masks and the growing geriatric population has been adding significant revenues to the market.

At what rate did demand Artificial Ventilation and Anaesthesia Masks increase over the past 6 years?

The Artificial Ventilation and Anaesthesia Masks Market expanded at 5.7% from 2017 through 2021.

Where are Artificial Ventilation and Anaesthesia Masks used the most?

Artificial Ventilation and Anaesthesia Masks are used the most in Operation Rooms. Revenue through this category expanded at a CAGR of 5.5% from 2017 to 2021, and is projected to grow at a CAGR of 4.8% by 2032.

Who are the key players shaping the Artificial Ventilation and Anaesthesia Masks Industry?

CareFusion Corporation, Air Liquide Healthcare, Koninklijke Philips N.V., ResMed, Ambu A/S, Acutronic Medical Systems, GaleMed, are some of the key players in the Artificial Ventilation and Anaesthesia Masks Industry.

Who are the top 5 countries driving the highest Artificial Ventilation and Anaesthesia Masks?

The United States, The United Kingdom, China, Japan and South Korea are expected to drive the most Artificial Ventilation and Anaesthesia Masks.

Which country has the largest market for Artificial Ventilation and Anaesthesia Masks?

The United States has the largest market for Artificial Ventilation and Anaesthesia Masks.